Injectable, in situ forming poly(propylene fumarate)-based ocular drug delivery systems

Journal of Biomedical Materials Research - Part A

Volumn 83, Issue 3, 2007, Pages 656-666

  Ueda, H ^a,c   Hacker, M C ^a   Haesslein, A ^a   Jo, S ^a,d   Ammon, D M ^b   Borazjani, R N ^b   Kunzler, J F ^b   Salamone, J C ^b   Mikos, A G ^a  

^a Rice University   (United States)

^b BAUSCH AND LOMB   (United States)

^c KYOTO UNIVERSITY   (Japan)

^d UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Fluocinolone acetonide; Injectable drug delivery; Long term release; N methyl 2 pyrrolidone; Poly(propylene fumarate); Solvent extraction

Indexed keywords

DELIVERY DEVICES; FLUOCINOLONE ACETONIDE; INJECTABLE DRUG DELIVERY; LONG-TERM RELEASE;

BIOCOMPATIBILITY; CROSSLINKING; DIFFUSION; DRUG PRODUCTS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; POLYPROPYLENES; SOLVENT EXTRACTION;

DRUG DELIVERY;

1 METHYL 2 PYRROLIDINONE; FLUOCINOLONE ACETONIDE; POLY(PROPYLENE FUMARATE); UNCLASSIFIED DRUG;

AQUEOUS HUMOR; ARTICLE; CROSS LINKING; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

DELAYED-ACTION PREPARATIONS; EYE; FLUOCINOLONE ACETONIDE; FUMARATES; GLUCOCORTICOIDS; KINETICS; POLYPROPYLENES; PYRROLIDINONES;

EID: 36048965220     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.31226     Document Type: Article

References (28)

1. Peyman GA, Ganiban GJ. Delivery systems for intraocular routes. Adv Drug Deliv Rev 1995;16:107-123.
2. Cunha-Vaz JG. The blood-retinal barriers system. Basic concepts and clinical evaluation. Exp Eye Res 2004;78:715-721.
3. Colthurst MJ, Williams RL, Hiscott PS, Grierson I. Biomaterials used in the posterior segment of the eye. Biomaterials 2000;21:649-665.
4. Yasukawa T, Ogura Y, Tabata Y, Kimura H, Wiedemann P, Honda Y. Drug delivery systems for vitreoretinal diseases. Prog Retin Eye Res 2004;23:253-281.
5. Yasukawa T, Kimura H, Tabata Y, Ogura Y. Biodegradable scleral plugs for vitreoretinal drug delivery. Adv Drug Deliv Rev 2001;52:25-36.
6. Kimura H, Ogura Y. Biodegradable polymers for ocular drug delivery. Ophthalmologic 2001;215:143-155.
7. Dunn RL, English JP, Cowsar DR, Vanderbilt DP. Biodegradable in-situ forming implants and methods of producing the same. US Patent No 4,938,763 (1990).
8. Shively ML, Coonts BA, Renner WD, Southard JL, Bennett AT. Physico-chemical characterization of a polymeric injectable implant delivery system. J Control Release 1995;33:237-243.
9. Hatefi A, Amsden B. Biodegradable injectable in situ forming drug delivery systems. J Control Release 2002;80:9-28.
10. Royals MA, Fujita SM, Yewey GL, Rodriguez J, Schultheiss PC, Dunn RL. Biocompatibility of a biodegradable in situ forming implant system in rhesus monkeys. J Biomed Mater Res 1999;45:231-239.
11. Shi X, Mikos AG. Poly (propylene fumarate). In: Guelcher SA, Hollinger JO, editors. An Introduction to Biomaterials. Boca Raton, FL: CRC Press; 2006. pp 205-218.
12. Haesslein A, Ueda H, Hacker MC, Jo S, Ammon DM, Borazjani RN, Kunzler JF, Salamone JC, Mikos AG. Long-term release of fluocinolone acetonide using biodegradable fumarate-based polymers. J Control Release 2006;114:251-260.
13. Scott RA, Peppas NA. Highly crosslinked, PEG-containing copolymers for sustained solute delivery. Biomaterials 1999;20:1371-1380.
14. Kempen DHR, Lu L, Zhu X, Kim C, Jabbari E, Dhert WJA, Currier BL, Yaszemski MJ. Development of biodegradable poly(propylene fumarate)/poly(lactic- co-glycolic acid) blend microspheres. II. Controlled drug release and microsphere degradation. J Biomed Mater Res A 2004;70:293-302.
15. Huang G, Gao J, Hu Z, John JV, Ponder BC, Moro D. Controlled drug release from hydrogel nanoparticle networks. J Control Release 2004;94:303-311.
16. Okabe J, Kimura H, Kunou N, Okabe K, Kato A, Ogura Y. Biodegradable intrascleral implant for sustained intraocular delivery of betamethasone phosphate. Invest Ophthalmol Vis Sci 2003;44:740-744.
17. Sherif Z, Pleyer U. Corticosteroids in ophthalmology: Past-present-future. Ophthalmologica 2002;216:305-315.
18. Jaffe GJ, Yang CH, Guo H, Denny JP, Lima C, Ashton P. Safety and pharmacokinetics of an intraocular fluocinolone acetonide sustained delivery device. Invest Ophthalmol Vis Sci 2000;41:3569-3575.
19. Shung AK, Timmer MD, Jo S, Engel PS, Mikos AG. Kinetics of poly(propylene fumarate) synthesis by step polymerization of diethyl fumarate and propylene glycol using zinc chloride as a catalyst. J Biomater Sci Polym Ed 2002;13:95-108.
20. Packhaeuser CB, Schnieders J, Oster CG, Kissel T. In situ forming parenteral drug delivery systems: An overview. Eur J Pharm Biopharm 2004;58:445-455.
21. Kranz H, Brazeau GA, Napaporn J, Martin RL, Millard W, Bodmeier R. Myotoxicity studies of injectable biodegradable in-situ forming drug delivery systems. Int J Pharm 2001;212:11-18.
22. Timmer MD, Ambrose CG, Mikos AG. Evaluation of thermal-and photo-crosslinked biodegradable poly(propylene fumarate)-based networks. J Biomed Mater Res A 2003;66:811-818.
23. Elisseeff J, Anseth K, Sims D, McIntosh W, Randolph M, Langer R. Transdermal photopolymerization for minimally invasive implantation. Proc Natl Acad Sci USA 1999;96:3104-3107.
24. Brodbeck KJ, DesNoyer JR, McHugh AJ. Phase inversion dynamics of PLGA solutions related to drug delivery. II. The role of solution thermodynamics and bath-side mass transfer. J Control Release 1999;62:333-344.
25. Graham PD, Brodbeck KJ, McHugh AJ. Phase inversion dynamics of PLGA solutions related to drug delivery. J Control Release 1999;58:233-245.
26. Raman C, McHugh AJ. A model for drug release from fast phase inverting injectable solutions. J Control Release 2005;102:145-157.
27. Jaffe GJ, McCallum RM, Branchaud B, Skalak C, Butuner Z, Ashton P. Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis. Ophthalmology 2005;112:1192-1198.
28. Jaffe GJ, Ben-nun J, Guo H, Dunn JP, Ashton P. Fluocinolone acetonide sustained drug delivery device to treat severe uveitis. Ophthalmology 2000;107:2024-2033.